A new model to study neurodegeneration in ataxia oculomotor apraxia type 2

Human Molecular Genetics

Volumn 24, Issue 20, 2015, Pages 5759-5774

  Becherel, Olivier J ^a,b   Sun, Jane ^b   Yeo, Abrey J ^a,b   Nayler, Sam ^b   Fogel, Brent L ^c   Gao, Fuying ^c   Coppola, Giovanni ^c   Criscuolo, Chiara ^d   De Michele, Giuseppe ^d   Wolvetang, Ernst ^b   Lavin, Martin F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; SENATAXIN; UNCLASSIFIED DRUG; RNA HELICASE; SETX PROTEIN, HUMAN;

ARTICLE; ATAXIA OCULOMOTOR APRAXIA TYPE 2; AUTOSOMAL RECESSIVE DISORDER; CELL DEATH; CEREBELLAR ATAXIA; CONTROLLED STUDY; DISEASE MODEL; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; FEMALE; FIBROBLAST; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEURAL STEM CELL; NUCLEAR REPROGRAMMING; NUCLEIC ACID STRUCTURE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MOUSE; MUTATION; NERVE CELL; PHYSIOLOGY; SPINOCEREBELLAR ATAXIAS;

ANIMALS; APOPTOSIS; CELLULAR REPROGRAMMING; DISEASE MODELS, ANIMAL; DNA BREAKS, DOUBLE-STRANDED; FEMALE; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MUTATION; NEURAL STEM CELLS; NEURONS; OXIDATIVE STRESS; RNA HELICASES; SPINOCEREBELLAR ATAXIAS;

EID: 84943804276     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv296     Document Type: Article

References (60)

1. Moreira, M.C., Klur, S.,Watanabe, M., Nemeth, A.H., Le Ber, I., Moniz, J.C., Tranchant, C., Aubourg, P., Tazir, M., Schols, L. et al. (2004) Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat. Genet., 36, 225-227.
2. Anheim, M., Monga, B., Fleury, M., Charles, P., Barbot, C., Salih, M., Delaunoy, J.P., Fritsch, M., Arning, L., Synofzik, M. et al. (2009) Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain, 132, 2688-2698.
3. Suraweera, A., Becherel, O.J., Chen, P., Rundle, N., Woods, R., Nakamura, J., Gatei, M., Criscuolo, C., Filla, A., Chessa, L. et al. (2007) Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage. J. Cell Biol., 177, 969-979.
4. Suraweera, A., Lim, Y., Woods, R., Birrell, G.W., Nasim, T., Becherel, O.J. and Lavin, M.F. (2009) Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum. Mol. Genet., 18, 3384-3396.
5. Skourti-Stathaki, K., Proudfoot, N.J. and Gromak, N. (2011) Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol. Cell, 42, 794-805.
6. Yuce, O. and West, S.C. (2013) Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol. Cell. Biol., 33, 406-417.
7. Groh, M. and Gromak, N. (2014) Out of balance: R-loops in human disease. PLoS Genet., 10, e1004630.
8. Richard, P., Feng, S. and Manley, J.L. (2013) A SUMO-dependent interaction between senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage. Genes Dev., 27, 2227-2232.
9. Becherel, O.J., Yeo, A.J., Stellati, A., Heng, E.Y., Luff, J., Suraweera, A.M., Woods, R., Fleming, J., Carrie, D., McKinney, K. et al. (2013) Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing. PLoS Genet., 9, e1003435.
10. Fogel, B.L., Cho, E.,Wahnich, A., Gao, F., Becherel, O.J.,Wang, X., Fike, F., Chen, L., Criscuolo, C., De Michele, G. et al. (2014) Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2. Hum. Mol. Genet., 23, 4758-4769.
11. Yeo, A.J., Becherel, O.J., Luff, J.E., Cullen, J.K.,Wongsurawat, T., Jenjaroenpoon, P., Kuznetsov, V.A., McKinnon, P.J. and Lavin, M.F. (2014) R-loops in proliferating cells but not in the brain:implications for AOA2 and other autosomal recessive ataxias. PloS ONE, 9, e90219.
12. Muguruma, K., Nishiyama, A., Kawakami, H., Hashimoto, K. and Sasai, Y. (2015) Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. Cell Rep., 10, 537-550.
13. Chan, E.M., Ratanasirintrawoot, S., Park, I.H., Manos, P.D., Loh, Y.H., Huo, H., Miller, J.D., Hartung, O., Rho, J., Ince, T.A. et al. (2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol., 27, 1033-1037.
14. Boguslawski, S.J., Smith, D.E., Michalak, M.A., Mickelson, K.E., Yehle, C.O., Patterson, W.L. and Carrico, R.J. (1986) Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids. J. Immunol. Meth., 89, 123-130.
15. El Hage, A., French, S.L., Beyer, A.L. and Tollervey, D. (2010) Loss of topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis. Genes Dev., 24, 1546-1558.
16. Marinello, J., Chillemi, G., Bueno, S., Manzo, S.G. and Capranico, G. (2013) Antisense transcripts enhanced by camptothecin at divergent CpG-island promoters associated with bursts of topoisomerase I-DNA cleavage complex and Rloop formation. Nucleic Acids Res., 41, 10110-10123.
17. Nayler, S., Gatei, M., Kozlov, S., Gatti, R., Mar, J.C.,Wells, C.A., Lavin, M. and Wolvetang, E. (2012) Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Trans. Med., 1, 523-535.
18. Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S. and Bonner, W.M. (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem., 273, 5858-5868.
19. Vantaggiato, C., Bondioni, S., Airoldi, G., Bozzato, A., Borsani, G., Rugarli, E.I., Bresolin, N., Clementi, E. and Bassi, M.T. (2011) Senataxin modulates neurite growth through fibroblast growth factor 8 signalling. Brain, 134, 1808-1828.
20. Airoldi, G., Guidarelli, A., Cantoni, O., Panzeri, C., Vantaggiato, C., Bonato, S., Grazia D'Angelo, M., Falcone, S., De Palma, C., Tonelli, A. et al. (2010) Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin. Neurogenetics, 11, 91-100.
21. De Amicis, A., Piane, M., Ferrari, F., Fanciulli, M., Delia, D. and Chessa, L. (2011) Role of senataxin in DNA damage and telomeric stability. DNA Repair (Amst.), 10, 199-209.
22. Roda, R.H., Rinaldi, C., Singh, R., Schindler, A.B. and Blackstone, C. (2014) Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage. J. Clin. Neurosci., 21, 1627-1631.
23. Miller, M.S., Rialdi, A., Ho, J.S., Tilove, M., Martinez-Gil, L., Moshkina, N.P., Peralta, Z., Noel, J., Melegari, C., Maestre, A. M. et al. (2015) Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis. Nat. Immunol., 16, 485-494.
24. Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A.S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G.B., Gunnarsdottir, S. et al. (2008) Genetics of gene expression and its effect on disease. Nature, 452, 423-428.
25. MacLennan, N.K., Dong, J., Aten, J.E., Horvath, S., Rahib, L., Ornelas, L., Dipple, K.M. and McCabe, E.R. (2009)Weighted gene co-expression network analysis identifies biomarkers in glycerol kinase deficient mice. Mol. Genet. Metab., 98, 203-214.
26. Saris, C.G., Horvath, S., van Vught, P.W., van Es, M.A., Blauw, H.M., Fuller, T.F., Langfelder, P., DeYoung, J.,Wokke, J.H., Veldink, J.H. et al. (2009) Weighted gene co-expression network analysis of the peripheral blood from amyotrophic lateral sclerosis patients. BMC Genomics, 10, 405.
27. Winden, K.D., Karsten, S.L., Bragin, A., Kudo, L.C., Gehman, L., Ruidera, J., Geschwind, D.H. and Engel, J. Jr. (2011) A systems level, functional genomics analysis of chronic epilepsy. PloS ONE, 6, e20763.
28. Miller, J.A., Woltjer, R.L., Goodenbour, J.M., Horvath, S. and Geschwind, D.H. (2013) Genes and pathways underlying regional and cell type changes in Alzheimer's disease. Genome Med., 5, 48.
29. Tian, Y., Voineagu, I., Pasca, S.P.,Won, H., Chandran, V., Horvath, S., Dolmetsch, R.E. and Geschwind, D.H. (2014) Alteration in basal and depolarization induced transcriptional network in iPSC derived neurons from Timothy syndrome. Genome Med., 6, 75.
30. Lavin, M.F., Yeo, A.J. and Becherel, O.J. (2013) Senataxin protects the genome: implications for neurodegeneration and other abnormalities. Rare Dis., 1, e25230.
31. Lee, D.Y. and Clayton, D.A. (1998) Initiation of mitochondrial DNA replication by transcription and R-loop processing. J. Biol. Chem., 273, 30614-30621.
32. Lin, M.T. and Beal, M.F. (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443, 787-795.
33. Lobsiger, C.S. and Cleveland, D.W. (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci., 10, 1355-1360.
34. Kailasan Vanaja, S., Rathinam, V.A., Atianand, M.K., Kalantari, P., Skehan, B., Fitzgerald, K.A. and Leong, J.M. (2014) Bacterial RNA:DNA hybrids are activators of the NLRP3 inflammasome. Proc. Natl Acad. Sci. USA, 111, 7765-7770.
35. Mankan, A.K., Schmidt, T., Chauhan, D., Goldeck, M., Honing, K., Gaidt, M., Kubarenko, A.V., Andreeva, L., Hopfner, K.P. and Hornung, V. (2014) Cytosolic RNA:DNA hybrids activate the cGAS-STING axis. EMBO J., 33, 2937-2946.
36. Rigby, R.E., Webb, L.M., Mackenzie, K.J., Li, Y., Leitch, A., Reijns, M.A., Lundie, R.J., Revuelta, A., Davidson, D.J., Diebold, S. et al. (2014) RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J., 33, 542-558.
37. Mason, S., Piper, M., Gronostajski, R.M. and Richards, L.J. (2009) Nuclear factor one transcription factors in CNS development. Mol. Neurobiol., 39, 10-23.
38. Uittenbogaard, M., Baxter, K.K. and Chiaramello, A. (2010) The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. ASN Neuro, 2, e00034.
39. Greer, E.L. and Shi, Y. (2012) Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet., 13, 343-357.
40. Li, X.M., Yu, C., Wang, Z.W., Zhang, Y.L., Liu, X.M., Zhou, D., Sun, Q.Y. and Fan, H.Y. (2013) DNA topoisomerase II is dispensable for oocyte meiotic resumption but is essential for meiotic chromosome condensation and separation in mice. Biol. Reprod., 89, 118.
41. Zhao, L., Mandler, M.D., Yi, H. and Feng, Y. (2010) Quaking I controls a unique cytoplasmic pathway that regulates alternative splicing of myelin-associated glycoprotein. Proc. Natl Acad. Sci. USA, 107, 19061-19066.
42. Martins-Taylor, K., Schroeder, D.I., LaSalle, J.M., Lalande, M. and Xu, R.H. (2012) Role of DNMT3B in the regulation of early neural and neural crest specifiers. Epigenetics, 7, 71-82.
43. Hashimoto, H., Horton, J.R., Zhang, X. and Cheng, X. (2009) UHRF1, a modular multi-domain protein, regulates replication- coupled crosstalk between DNA methylation and histone modifications. Epigenetics, 4, 8-14.
44. Yeo, A.J., Becherel, O.J., Luff, J.E., Graham, M.E., Richard, D. and Lavin, M.F. (2015) Senataxin controls meiotic silencing through ATR activation and chromatin remodelling. Cell Discovery, [in press].
45. Hardy, R.J. (1998) QKI expression is regulated during neuronglial cell fate decisions. J. Neurosci. Res., 54, 46-57.
46. Kitaoka, Y., Munemasa, Y., Kojima, K., Hirano, A., Ueno, S. and Takagi, H. (2013) Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration. Cell Death Dis., 4, e860.
47. Meyer-Lindenberg, A., Straub, R.E., Lipska, B.K., Verchinski, B. A., Goldberg, T., Callicott, J.H., Egan, M.F., Huffaker, S.S., Mattay, V.S., Kolachana, B. et al. (2007) Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J. Clin. Invest., 117, 672-682.
48. Oda, K., Shiratsuchi, T., Nishimori, H., Inazawa, J., Yoshikawa, H., Taketani, Y., Nakamura, Y. and Tokino, T. (1999) Identification of BAIAP2 (BAI-associated protein 2), a novel human homologue of hamster IRSp53, whose SH3 domain interacts with the cytoplasmic domain of BAI1. Cytogenet. Cell Genet., 84, 75-82.
49. Shi, G.X., Cai, W. and Andres, D.A. (2013) Rit subfamily small GTPases: regulators in neuronal differentiation and survival. Cell Signal., 25, 2060-2068.
50. Nishimura-Akiyoshi, S., Niimi, K., Nakashiba, T. and Itohara, S. (2007) Axonal netrin-Gs transneuronally determine lamina- specific subdendritic segments. Proc. Natl Acad. Sci. USA, 104, 14801-14806.
51. Pappas, D.J., Coppola, G., Gabatto, P.A., Gao, F., Geschwind, D. H., Oksenberg, J.R. and Baranzini, S.E. (2009) Longitudinal system- based analysis of transcriptional responses to type I interferons. Physiol. Genomics, 38, 362-371.
52. Yu, Q., Katlinskaya, Y.V., Carbone, C.J., Zhao, B., Katlinski, K. V., Zheng, H., Guha, M., Li, N., Chen, Q., Yang, T. et al. (2015) DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function. Cell Rep., 11, 785-797.
53. Lavin, M.F. (2013) The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration. DNA Repair (Amst.), 12, 612-619.
54. Rulten, S.L. and Caldecott, K.W. (2013) DNA strand break repair and neurodegeneration. DNA Repair (Amst.), 12, 558-567.
55. Muguruma, K., Nishiyama, A., Ono, Y., Miyawaki, H., Mizuhara, E., Hori, S., Kakizuka, A., Obata, K., Yanagawa, Y., Hirano, T. et al. (2010) Ontogeny-recapitulating generation and tissue integration of ES cell-derived Purkinje cells. Nat. Neurosci., 13, 1171-1180.
56. Yu, J.,Hu, K.,Smuga-Otto, K.,Tian, S.,Stewart,R., Slukvin, II.and Thomson, J.A. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797-801.
57. Xu, R.H., Peck, R.M., Li, D.S., Feng, X., Ludwig, T. and Thomson, J.A. (2005) Basic FGF and suppression ofBMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Meth., 2, 185-190.
58. Wettenhall, J.M. and Smyth, G.K. (2004) limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics, 20, 3705-3706.
59. Hatchi, E., Skourti-Stathaki, K., Ventz, S., Pinello, L., Yen, A., Kamieniarz-Gdula, K., Dimitrov, S., Pathania, S., McKinney, K.M., Eaton, M.L. et al. (2015) BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair. Mol. Cell, 57, 636-647.
60. Vantaggiato, C., Cantoni, O., Guidarelli, A., Romaniello, R., Citterio, A., Arrigoni, F., Doneda, C., Castelli, M., Airoldi, G., Bresolin, N. et al. (2004) Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents. Brain Dev., 36, 682-689.